NASDAQ · MBX
MBX Biosciences, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for MBX: Nov 5, 2026
MBX Biosciences, Inc. Common Stock is estimated to report earnings on 11/05/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.8. The reported EPS for the same quarter last year was $-0.63.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.80 | $-0.69 | $-0.88 | 4 |
| Dec 2026 | $-0.87 | $-0.80 | $-0.94 | 4 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Fintel · MarketBeat- RTTNews · Aug 27, 9:16 AM EDTMBX Biosciences Advances Canvuparatide Into Phase 3 Development For Hypoparathyroidism(RTTNews) – MBX Biosciences (MBX) announced that the first patient has been dosed in its pivotal Phase 3 oPTimize trial evaluating once-weekly canvuparatide for the treatment of chronic hypoparathyroidism (HP).
- RTTNews · Jun 24, 10:04 AM EDT6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & More(RTTNews) – "The market is a device for transferring money from the impatient to the patient." – Warren Buffett.
- RTTNews · Jun 11, 11:54 PM EDTTop Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch…(RTTNews) – Today's top gainers were led by Australia-based Gelteq, which develops a novel ingestible gel-based drug delivery platform; Adial Pharmaceuticals, which announced the acquisition of Azora Therapeutics as part of its pipeline expansion strategy; Precigen, which is draw
- The Motley Fool · May 27, 3:38 PM EDTChief Medical Officer Sells MBX for $2.7 Million After Monster 2026 RunChief Medical Officer Salomon Azoulay exercised and sold 70,003 shares on May 8, 2026, for a transaction value of ~$2.69 million at a weighted average price of around $38.36 per share.
- Fintel · May 13, 9:48 PM EDTMBX Biosciences (MBX) Price Target Increased by 11.23% to 69.55The average one-year price target for MBX Biosciences (NasdaqGS:MBX) has been revised to $69.55 / share. This is an increase of 11.23% from the prior estimate of $62.53 dated April 25, 2026. The price target is an average of many targets provided by analysts.
- MarketBeat · May 11, 3:09 PM EDTMBX Biosciences Obesity Day Spotlights Monthly GLP-1 Hope and Pipeline PushMBX Biosciences (NASDAQ:MBX) used its Obesity Day event to outline preliminary clinical data for its lead obesity candidate MBX 4291, introduce a new preclinical obesity program and reiterate key development milestones across its endocrine and metabolic disease pipeline. Preside
- The Motley Fool · May 5, 9:05 AM EDT3 Overlooked Stocks Set to Soar in 2026Axsome Therapeutics and NovoCure Limited recently received FDA approvals for their therapies.
- The Motley Fool · Apr 22, 11:00 AM EDTAaron Wealth Makes a Big Bet on MBX Biosciences With a 1.1 Million Share PurchaseAaron Wealth Advisors LLC bought 1,098,176 shares of MBX Biosciences; estimated transaction value $37.35 million based on quarterly average pricing
- The Motley Fool · Mar 26, 12:04 PM EDTMBX CEO Buys 18,500 Shares as Stock Jumps 270% This Past Year. Here's What You Should KnowThe president & CEO of MBX Biosciences reported the acquisition of 18,500 indirectly held shares for about $526,000 on March 13, 2026.
- BNK Invest · Mar 18, 2:07 PM EDTWednesday 3/18 Insider Buying Report: MDRR, MBXAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. On Friday, Medalist Diversified's CHAIRMAN, CEO & PRESIDENT, Frank Kavanaugh, m
- BNK Invest · Mar 9, 4:44 PM EDTMbx Biosciences is Now Oversold (MBX)Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
- BNK Invest · Jan 29, 7:07 AM ESTAdd Up The Parts: IHE Could Be Worth $96Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for MBX Biosciences, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.